XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2022
May 11, 2022
Document Type 10-Q  
Entity Central Index Key 0001534248  
Document Period End Date Mar. 31, 2022  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-38807  
Entity Registrant Name Chemomab Therapeutics Ltd.  
Entity Incorporation, State or Country Code L3  
Entity Tax Identification Number 81-3676773  
Entity Address, Address Line One Kiryat Atidim  
Entity Address, Address Line Two Building 7  
Entity Address, City or Town Tel Aviv  
Entity Address, Postal Zip Code 6158002  
Entity Address, Country IL  
City Area Code 972  
Local Phone Number 77-331-0156  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   11,404,515
American Depositary Shares [Member]    
Title of 12(b) Security American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share  
Trading Symbol CMMB  
Name of Exchange on which Security is Registered NASDAQ  
Ordinary Shares, No Par Value Per Share [Member]    
Title of 12(b) Security Ordinary shares, no par value per share  
Trading Symbol n/a  
Name of Exchange on which Security is Registered NASDAQ